North America Vaccine Contract Manufacturing Market Size & Outlook
North America vaccine contract manufacturing market, 2018-2030 (US$M)
Related Markets
North America vaccine contract manufacturing market highlights
- The North America vaccine contract manufacturing market generated a revenue of USD 1,418.3 million in 2023.
- The market is expected to grow at a CAGR of 5.5% from 2024 to 2030.
- In terms of segment, attenuated vaccine was the largest revenue generating vaccine type in 2023.
- DNA Vaccines is the most lucrative vaccine type segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 1,418.3 million |
| Market revenue in 2030 | USD 2,069.0 million |
| Growth rate | 5.5% (CAGR from 2023 to 2030) |
| Largest segment | Attenuated vaccine |
| Fastest growing segment | DNA Vaccines |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Attenuated Vaccine, Inactivated Vaccine, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines |
| Key market players worldwide | Lonza Group Ltd, FUJIFILM Holdings Corp, Merck KGaA, Catalent Inc, Icon PLC, Syngene, Curia, Ajinomoto Co Inc, IDT Biologika |
Other key industry trends
- In terms of revenue, North America region accounted for 33.6% of the global vaccine contract manufacturing market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,981.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Vaccine Contract Manufacturing Market Scope
Vaccine Contract Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America vaccine contract manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to vaccine contract manufacturing market will help companies and investors design strategic landscapes.
Attenuated vaccine was the largest segment with a revenue share of 29.94% in 2023. Horizon Databook has segmented the North America vaccine contract manufacturing market based on attenuated vaccine, inactivated vaccine, subunit vaccines, toxoid vaccines, dna vaccines covering the revenue growth of each sub-segment from 2018 to 2030.
North America held the largest market share in the global market, with the U.S. accounting for the dominant share in North America. This can be attributed to the presence of a substantial number of vaccine contract manufacturers in the U.S. Presence of an effective regulatory framework for biologics, including vaccines, contributed to the growth of the regional market in 2023.
Furthermore, initiatives undertaken by government bodies to increase vaccination coverage and reduce incidence of vaccine-preventable illness are anticipated to maintain growth of this regional market throughout the forecast period.
In addition, local Contract Manufacturing Organizations (CMOs) are investing significantly in expanding their manufacturing facilities, which is expected to drive the regional market in the future.
Reasons to subscribe to North America vaccine contract manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America vaccine contract manufacturing market databook
-
Our clientele includes a mix of vaccine contract manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America vaccine contract manufacturing market , including forecasts for subscribers. This continent databook contains high-level insights into North America vaccine contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America vaccine contract manufacturing market size, by country, 2018-2030 (US$M)
North America Vaccine Contract Manufacturing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
